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Abstract
Introduction:  Mycobacterium avium complex (MAC) is an increasingly recognized cause of
pulmonary disease in immunocompetent individuals. An acute form of MAC lung disease, MAC-
associated pneumonitis, has generally been associated with the use of hot tubs. There is
controversy in the literature about whether MAC-associated pneumonitis is a classic
hypersensitivity pneumonitis or is a direct manifestation of mycobacterial infection.
Case presentation: We report the second case in the literature of MAC-associated pneumonitis
not related to the use of hot tubs. The source of MAC in a 52-year-old immunocompetent patient
was an intrapulmonary cyst containing numerous acid-fast bacilli. The patient developed
disseminated miliary nodules throughout both lung fields. Histological examination of resected lung
tissue revealed well-formed, acid-fast negative granulomas composed predominantly of CD4+ T-
cells and CD68+ histiocytes. The granulomas were strongly positive for tumor necrosis factor-α, a
pro-inflammatory cytokine.
Conclusion:  The attempt to classify MAC-associated pneumonitis as either a classic
hypersensitivity pneumonitis or a direct manifestation of mycobacterial infection is not particularly
useful. Our case demonstrates that MAC-associated pneumonitis is characterized by a vigorous T-
helper 1-like, pro-inflammatory, immune response to pulmonary mycobacterial infection. The
immunopathology provides a rationale for clinical studies of anti-MAC therapy with the addition of
anti-inflammatory agents (for example, corticosteroids) to hasten the resolution of infection and
symptoms.
Introduction
Mycobacterium avium complex (MAC)-associated pneu-
monitis has typically been reported in immunocompetent
persons exposed to aerosolized MAC from indoor or out-
door hot tubs (termed "hot tub lung") [1-3]. There is con-
troversy in the literature about whether the illness is a
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classic hypersensitivity pneumonitis or is a direct manifes-
tation of mycobacterial infection. Histopathologic and
bronchoscopic differences have been described between
classic hypersensitivity pneumonitis and MAC-associated
pneumonitis [2,4].
We present here the second reported case of MAC-associ-
ated pneumonitis that was not associated with the use of
hot tubs [2]. The pathological features of this case of
MAC-associated hypersensitivity pneumonitis stress the
differences between 'classic' hypersensitivity pneumonitis
and MAC-associated pneumonitis. These differences have
important implications for the diagnosis as well as for the
treatment of MAC-associated pneumonitis. Our report
also highlights the clinical importance of alternative
sources of MAC that can lead to a hypersensitivity pneu-
monitis.
Case presentation
A 52-year-old man presented with two weeks of dyspnea
and a productive cough. A high-resolution computed
tomography (HRCT) scan of the chest showed a left lower
lobe cyst with an air-fluid level and adjacent infiltrate
(Figure 1a). He was treated with levofloxacin, which
resolved the symptoms. Six months later he began to
experience fatigue, dyspnea and a productive cough. A
chest radiograph showed complete opacification of the
cyst in the left lower lobe. He was treated empirically with
azithromycin and levofloxacin, without improvement. A
bronchoscopy with bronchoalveolar lavage was unreveal-
ing. Routine bacterial, acid-fast bacilli (AFB), and fungal
stains and cultures were negative. After four weeks, the
patient continued to have a productive cough and fatigue,
worsening dyspnea, weight loss and fevers. He was admit-
ted to the hospital for resection of a presumed non-resolv-
ing lung abscess.
His past medical history was unremarkable. He did not
take any immunosuppressive medications and had no
exposure to hot tubs. Physical examination revealed mild
hypoxemia and coarse rales over the left lower lung field.
White blood cell count was 12,400/mm3. HIV serology
was negative, as was a tuberculin skin test. Blood and
urine cultures were negative. A pre-operative HRCT
showed a new diffuse pattern of miliary nodules through-
out both lung fields (Figure 1b). No ground glass opaci-
ties were seen. Because of the central location of the lesion
a left lower lobectomy was performed. Examination of the
resected lobe revealed a cyst filled with thick yellow fluid
that was AFB positive on a smear. Cultures from the cyst
fluid eventually grew MAC; bacterial and fungal cultures
were negative.
The patient was initially placed on a four-drug anti-tuber-
culosis regimen. After identification of MAC in the cul-
ture, his antibiotic regimen was changed to azithromycin,
ethambutol, and rifampin. His respiratory symptoms
resolved over the ensuing three months, with disappear-
ance of the miliary nodules on chest HRCT (Figure 1c).
Histologic examination of the resected lung lobe revealed
a bronchogenic cyst. The lung parenchyma surrounding
the cyst was replaced by well-formed granulomas that
were AFB negative (Figure 2a). The granulomas consisted
of central CD68+ macrophages surrounded by a mantle of
CD5+ T-lymphocytes, with some T-lymphocytes infiltrat-
ing the granulomas (Figure 2b). CD4+ T-cells constituted
the main lymphocytic component of the granulomas and
were closely associated with the CD68+ macrophages in
HRCT appearance of left lower lobe cyst, MAC-associated pneumonitis, and subsequent resolution Figure 1
HRCT appearance of left lower lobe cyst, MAC-associated pneumonitis, and subsequent resolution. (a) Left 
lower lobe cyst with air-fluid level and adjacent infiltrate at initial presentation. (b) Bilateral, diffuse miliary nodular pattern six 
months later. (c) Resolution of miliary pattern after 3 months of antimycobacterial treatment.Journal of Medical Case Reports 2008, 2:152 http://www.jmedicalcasereports.com/content/2/1/152
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the central core (Figure 2c). CD8+ T-cells were essentially
restricted to the periphery, and there was a paucity of
CD20+ B-cells in the perigranulomatous areas (Figure 2d).
The central core of the granulomas and the surrounding
tissue showed strong reactivity for tumor necrosis factor-α
(TNF-α) (Figure 3).
Discussion
MAC infection activated a vigorous immune response in
our patient that, together with the antimycobacterial regi-
men, likely contributed to the resolution of disease. The
antimycobacterial immune response was characterized by
well-formed granulomas with a low organism load,
increased CD4/CD8 ratio in the granulomas, and marked
TNF-α production. This T-helper 1-like immune response
Immunohistochemical staining for macrophages (CD68) and T-lymphocyte subsets (CD5, CD4, and CD8) in lung tissue biopsy Figure 2
Immunohistochemical staining for macrophages (CD68) and T-lymphocyte subsets (CD5, CD4, and CD8) in 
lung tissue biopsy. (a) Lung tissue with well-formed granulomas, hematoxylin and eosin stain, 200× magnification. (b) Anti-
CD68 (brown) and anti-CD5 (red) immunostaining, 400× magnification. (c) Anti-CD68 (brown) and anti-CD4 (red) immunos-
taining, 200× magnification. (d) Anti-CD68 (brown) and anti-CD8 (red) immunostaining, 40× magnification.Journal of Medical Case Reports 2008, 2:152 http://www.jmedicalcasereports.com/content/2/1/152
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is considered pivotal for the eradication of mycobacterial
pathogens. It is also somewhat different than what is
reported in classic hypersensitivity pneumonitis. The his-
tologic appearance of classic hypersensitivity pneumonitis
is characterized by poorly formed, non-necrotizing granu-
lomas, and patchy interstitial pneumonitis. It is described
as a combination of IgG-mediated and CD8+ > CD4+ T-
cell mediated hypersensitivity reactions [5]. One possible
exception is farmer's lung, which is often characterized by
increased CD4/CD8 ratios [6].
In our patient, the TNF-α+ CD4+ T-cell dominant granulo-
matous immune response produced clinical symptoms
and diffuse miliary nodules. The MAC organism load was
high in the cyst fluid, but low in the diffuse parenchymal
granulomas. This may suggest that heavy or continuous
exposure to MAC (for example, in hot tubs or, in this case,
from a heavily colonized cyst) promotes the development
of antimycobacterial T-helper 1-like immune responses in
the lung. This case is also a reminder that pulmonary
structural abnormalities may be a reservoir for triggering
MAC-associated pneumonitis.
Conclusion
The attempt to classify MAC-associated pneumonitis as
either a classic hypersensitivity pneumonitis or a direct
manifestation of mycobacterial infection is not particu-
larly useful. Our case demonstrates that MAC-associated
pneumonitis is caused by a vigorous T-helper 1-like
immune response to pulmonary MAC infection. The T-
helper 1-like antimycobacterial immune response is con-
sistent with the observation that MAC-associated pneu-
monitis is generally a self-limited disease [1].
Corticosteroids were not used in this case. However, the
observed immunopathology provides a rationale for clin-
ical studies of the use of anti-MAC therapy and anti-
inflammatory agents (for example, corticosteroids) to
hasten the resolution of infection and symptoms.
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